Catalyst Pharmaceuticals, Inc.

About Catalyst Pharmaceuticals, Inc.

Catalyst is a biopharmaceutical company dedicated to improving the lives of patients with rare diseases through innovative science and social responsibility.

Products & Services

Approved Products:Products that have been approved for use, specifics available on the company website.

Specialties

Rare Diseases Lambert-Eaton Myasthenic Syndrome (LEMS) Epilepsy Duchenne Muscular Dystrophy (DMD) Clinical Research Compassionate Use Programs

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 140100000 MR: - FA: $140.1 million FAN: 140100000	D: 2024-01-09 FD: 2024-01-09	7 investors
2	RT: Public Offering T: - FT: Public Offering	A: 150000000 MR: - FA: 150,000,000 FAN: 150000000	D: 2024-01-05 FD: 2024-01-05	7 investors
3	RT: Public Offering T: - FT: Public Offering	A: 150000000 MR: - FA: $150,000,000 FAN: 150000000	D: 2024-01-04 FD: 2024-01-04	6 investors

Public Offering Latest

2024-01-09

$140.1M

7 investors (Pro only)

Public Offering 2024-01-05

$150.0M

Public Offering 2024-01-04

$150.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

P

Patrick J. McEnany

Co-Founder and Chairman

R

Richard J. Daly

President and Chief Executive Officer

D

Daniel J. Curran

Managing Partner at Mountainfield Venture Partners and Chief Executive Officer of Timberline Therapeutics

D

Donald A. Denkhaus

Board Member and Chair of the Audit Committee

M

Molly Harper

Managing Partner

T

Tamar Thompson

Vice President, Patient Experience & Insights

View 12 more team members with Pro

Unlock Full Team Directory

Recent News